In this podcast titled “Opportunities and Challenges in Developing Innovative Stem Cell Therapies,” Dr. Armand Keating focuses specifically on the commercialization of mesenchymal stem cells (stromal cells). He has established the largest stem cell transplant program in Canada and his clinical and research interests focus on anti-cancer cell therapy, blood and marrow transplantation, leukemia, lymphoma and cell-based tissue regeneration. Dr. Keating is the Epstein Chair in Cell Therapy and Transplantation, University of Toronto, and Director of the Cell Therapy Program at the Princess Margaret Hospital, University Health Network (Toronto).
Click to hear podcast: Opportunities and Challenges in Developing Innovative Stem Cell Therapies
Our regular feature, Right Turn, showcases the “lighter” side of stem cells and regenerative medicine. Every Friday, we will bring you cartoons, photos, videos and other content that may be just as thought provoking as the written submissions that you are used to finding here, but they definitely won’t be blogs.
As always, we welcome your feedback and we also welcome suitable submissions. Be creative! Use the right (!) side of your brain. Make us laugh! Let’s see if we can make this new direction a positive one for all of us. Send your submission to info(at)ccrm.ca.
Latest posts by Stacey Johnson (see all)
- Right Turn: A new science twist on those old Christmas favourites - December 22, 2017
- Right Turn: Four STEM women to watch - December 15, 2017
- Right Turn: Canada 2067 – a STEM action plan - December 1, 2017